Toward Personalized Salbutamol Therapy: Validating Virtual Patient-Derived Population Pharmacokinetic Model with Real-World Data
Interindividual variability, influenced by patient-specific factors including age, weight, gender, race, and genetics, among others, contributes to variations in therapeutic response. Population pharmacokinetic (popPK) modeling is an essential tool for pinpointing measurable factors affecting dose-c...
Saved in:
Main Authors: | Lara Marques (Author), Nuno Vale (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prediction of CYP-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Modeling: A Case Study of Salbutamol and Fluvoxamine
by: Lara Marques, et al.
Published: (2023) -
Unraveling the Impact of Salbutamol Polytherapy: Clinically Relevant Drug Interactions
by: Lara Marques, et al.
Published: (2023) -
Harnessing Clinical Trial and Real-World Data Towards an Understanding of Sex Effects on Drug Pharmacokinetics, Pharmacodynamics and Efficacy
by: Joyce Oi Yan Chan, et al.
Published: (2022) -
Model‐based meta‐analysis of salbutamol pharmacokinetics and practical implications for doping control
by: Perrine Courlet, et al.
Published: (2022) -
Inhaled salbutamol intoxication
by: Cristina Elena Singer, et al.
Published: (2023)